Adeno-associated virus (AAV) injection AAV-U6-sh (NC2)-CMV-EGFP-WPRE (AAV-sh-Control, 2.70 10 13 v.g./mL) and AAV-U6-shRNA (Vgf)-CMV-EGFP-WPRE (AAV-sh-VGF, 9.52 10 12 v.g./mL) were obtained from Obio Technology (Shanghai, China)
[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Graham G.G., Punt J., Arora M., Day R.O., Doogue M.P., Duong J., Furlong T.J., Greenfield J.R., Greenup L.C., Kirkpatrick C.M., et al
all specimens were collected at Xinhua Hospital (Shanghai, China)
Dosing follows the standard compounded tirzepatide dosage progression: start at 2.5 mg per week for the first four weeks, then titrate up to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and eventually 15 mg depending on tolerance and clinical response
Post-surgical recovery enhancement: 43-year-old after retinal detachment repair